Healthcare Industry Hypodermic Needles Market Analysis | Page 2
Your Catalyst To a Lucrative Business
Worldwide, needlestick injuries are the primary concern for healthcare providers. In the U.S., every year,
approximately, 8 to 10 lac needlestick injuries occur to healthcare workers, and about 1000 of them get
contacted with infectious diseases, and 500 to 600 die each year due to these type of injuries. The cost of
needlestick injury follow-up in the U.S. per incident is approximately USD 3,000, and around USD 3 billion is
spent annually in the U.S. on needlestick injuries. Hence, the increasing occurrence of these type of injuries
results in the development of improved and effective safety needles.
Safety engineered devices (SEDs) are categorized into passive and active devices. Passive needles are highly
preferred over conventional needles owing to its advantages such as user-friendliness and others. Also, with
the implementation of the regulations promoting the use of safety hypodermic needles will further enhance the
acceptance of these needles over the forecast period. For instance, World Health Organization (WHO)
encourages injection safety worldwide through the Safe Injection Global Network (SIGN).
Exposure to needlestick injuries may cause severe blood-borne diseases such as HIV and Hepatitis. Owing to the
increasing occurrence of needlestick injuries, healthcare providers are shifting towards the use of safety
hypodermic needles. Furthermore, manufacturers are focusing on developing needles and syringes safety -
engineered mechanisms to avoid any injuries. For instance, BD has developed SafetyGlide, Vacutainer Eclipse
blood collection needle, and VanishPoint blood collection safety needle. Hence, increasing focus on the
development of advanced engineered mechanisms about the needles performance and efficiency will further
drive the growth.
Hexa Research has segmented the global hypodermic needle market based on type, end-use and region:
Segmentation by product type, 2014 - 2024 (USD Million)
• Safety Needle
• Non-safety Needle
Segmentation by end-user, 2014 - 2024 (USD Million)
• Hospitals & Clinic
• Diagnostic Lab
• Homecare
Segmentation by region, 2014 - 2024 (USD Million)
• North America
• U.S.
• Europe
• Germany
• Asia Pacific
• Japan
• China
• India
• Central & South America
• Brazil
• Middle East & Africa
Follow Us: